160 related articles for article (PubMed ID: 27165315)
21. Complex Reconstitution and Characterization by Combining Co-expression Techniques in Escherichia coli with High-Throughput.
Vincentelli R; Romier C
Adv Exp Med Biol; 2016; 896():43-58. PubMed ID: 27165318
[TBL] [Abstract][Full Text] [Related]
22. The Use of Small-Angle Scattering for the Characterization of Multi Subunit Complexes.
Round A
Adv Exp Med Biol; 2016; 896():329-50. PubMed ID: 27165335
[TBL] [Abstract][Full Text] [Related]
23. Targeted gene modifications in drug discovery and development.
Cabaniols JP; Mathis L; Delenda C
Curr Opin Pharmacol; 2009 Oct; 9(5):657-63. PubMed ID: 19525146
[TBL] [Abstract][Full Text] [Related]
24. Choose a Suitable Expression Host: A Survey of Available Protein Production Platforms.
Fernández FJ; Vega MC
Adv Exp Med Biol; 2016; 896():15-24. PubMed ID: 27165316
[TBL] [Abstract][Full Text] [Related]
25. Current trends in epigenetic drug discovery.
Stolfa DA; Einsle O; Sippl W; Jung M
Future Med Chem; 2012 Oct; 4(16):2029-37. PubMed ID: 23157236
[TBL] [Abstract][Full Text] [Related]
26. Latest approaches for efficient protein production in drug discovery.
Sugiki T; Fujiwara T; Kojima C
Expert Opin Drug Discov; 2014 Oct; 9(10):1189-204. PubMed ID: 25046062
[TBL] [Abstract][Full Text] [Related]
27. Drug discovery considerations in the development of covalent inhibitors.
Mah R; Thomas JR; Shafer CM
Bioorg Med Chem Lett; 2014 Jan; 24(1):33-9. PubMed ID: 24314671
[TBL] [Abstract][Full Text] [Related]
28. EDITORIAL: Medicinal Chemistry of Molecular and Epigenetic Targets and Dug Development.
Zhang L
Curr Top Med Chem; 2017; 17(15):1669. PubMed ID: 28589850
[No Abstract] [Full Text] [Related]
29. Extending kinome coverage by analysis of kinase inhibitor broad profiling data.
Jacoby E; Tresadern G; Bembenek S; Wroblowski B; Buyck C; Neefs JM; Rassokhin D; Poncelet A; Hunt J; van Vlijmen H
Drug Discov Today; 2015 Jun; 20(6):652-8. PubMed ID: 25596550
[TBL] [Abstract][Full Text] [Related]
30. Discovery and development of DNA methyltransferase inhibitors using in silico approaches.
Medina-Franco JL; Méndez-Lucio O; Dueñas-González A; Yoo J
Drug Discov Today; 2015 May; 20(5):569-77. PubMed ID: 25526932
[TBL] [Abstract][Full Text] [Related]
31. Accelerating the discovery of new drug targets with chemical proteomics.
Cheung AK; Jain RK
IDrugs; 2010 Dec; 13(12):862-8. PubMed ID: 21154144
[TBL] [Abstract][Full Text] [Related]
32. Baculovirus expression system for heterologous multiprotein complexes.
Berger I; Fitzgerald DJ; Richmond TJ
Nat Biotechnol; 2004 Dec; 22(12):1583-7. PubMed ID: 15568020
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of a hetero subunit RNA modification enzyme by the wheat germ cell-free translation system.
Hori H
Methods Mol Biol; 2010; 607():173-85. PubMed ID: 20204857
[TBL] [Abstract][Full Text] [Related]
34. Development and application of PI3K assays for novel drug discovery.
Yanamandra M; Mitra S; Giri A
Expert Opin Drug Discov; 2015 Feb; 10(2):171-86. PubMed ID: 25547459
[TBL] [Abstract][Full Text] [Related]
35. The Use of Antibodies in Small-Molecule Drug Discovery.
Marsden CJ; Eckersley S; Hebditch M; Kvist AJ; Milner R; Mitchell D; Warwicker J; Marley AE
J Biomol Screen; 2014 Jul; 19(6):829-38. PubMed ID: 24695620
[TBL] [Abstract][Full Text] [Related]
36. Structure-based drug discovery and protein targets in the CNS.
Hubbard RE
Neuropharmacology; 2011 Jan; 60(1):7-23. PubMed ID: 20673774
[TBL] [Abstract][Full Text] [Related]
37. Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer.
Verma SK; Knight SD
Future Med Chem; 2013 Sep; 5(14):1661-70. PubMed ID: 24047271
[TBL] [Abstract][Full Text] [Related]
38. Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target.
Plummer R
Clin Cancer Res; 2010 Sep; 16(18):4527-31. PubMed ID: 20823148
[TBL] [Abstract][Full Text] [Related]
39. Structure and function of G protein-coupled receptor oligomers: implications for drug discovery.
Schonenbach NS; Hussain S; O'Malley MA
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(3):408-27. PubMed ID: 25521522
[TBL] [Abstract][Full Text] [Related]
40. Protein-protein interactions: principles, techniques, and their potential role in new drug development.
Khan SH; Ahmad F; Ahmad N; Flynn DC; Kumar R
J Biomol Struct Dyn; 2011 Jun; 28(6):929-38. PubMed ID: 21469753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
